Cytel Corporation

San Diego, CA 92121

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $0.0
First Award Date 04/01/92
Most Recent Award Date 09/30/99

Key Personnel

Last Name Name Awards Contact
Vitello Maria A Vitello 1
Sette Alessandro Sette 3
Celis Esteban Celis 2
Chesnut Robert W Chesnut 2
Elices Mariano J Elices 1

9 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 09/29/00

DESCRIPTION: (Adapted from the applicant s abstract) The goal of the proposed studies is to design a multi-epitope-based vaccine for the treatment and prophylaxis of HCV-infected patients. Such a vaccine will be designed to induce antigen-specific CTL and HTL responses and provide broad population covera...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/98 - 09/29/99

DESCRIPTION: (Adapted from the applicant s abstract) The goal of the proposed studies is to design a multi-epitope-based vaccine for the treatment and prophylaxis of HCV-infected patients. Such a vaccine will be designed to induce antigen-specific CTL and HTL responses and provide broad population covera...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 03/29/98

The goal is to demonstrate that blocking an adhesion receptor involved in inflammation (i.e., the integrin VLA-4) has a therapeutic benefit in chronic inflammatory disease. Specifically we propose to assess efficacy of anti-adhesion treatment by looking oat three parameters: leukocyte infiltration, expressio...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/96 - 01/31/97

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/96 - 04/30/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/95 - 01/31/96

The overall aim of our studies is to derive a potential HCV vaccine, based on the induction of HCV-specific CTL. To do so, we propose in the present Phase I study, to identify a synthetic formulation composed of at least two A2-restricted CTL epitopes derived from conserved regions of the HCV genome. Such formulatio...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/95 - 04/30/96

Chronic hepatitis B virus infection is a serious worldwide health problem for which there is no effective treatment for most patients. The goal of the present proposal is to develop an HBV-specific vaccine capable of eliciting HLA class I-restricted CTL that will eliminate hepatitis B virus from chronically-infected patients . During the...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/95 - 06/30/95

Cancer of the prostate is a serious health problem both in the US and worldwide. In the US alone approximately 165,000 new cases of prostate cancer are diagnosed each year (Cancer Statistics 12993, CA Cancer J. Clin. 43:7-26, 1993), new types of treatments such as immunotherapy should be considered. The purpose of the present study is to e...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/92 - 09/30/92

DESCRIPTION: (Adapted from the Applicant's Abstract). Hepatitis B virus (HBV) is a hepatotropic virus that is a major public health concern worldwide. While a recombinant surface antigen vaccine is available, there is no effective treatment for the millions of individuals who are chronically infected. The objective of this proposal is to dev...